Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | MAB21L1 |
| Upstream (Parents) |
|---|
| (<<) PRICKLE2 → MAB21L1 |
| (<<) PDGFD → MAB21L1 |
| (<<) RAI2 → MAB21L1 |
| (<<) SPARCL1 → MAB21L1 |
| Downstream (Children) |
|---|
| MAB21L1 → TMX4 (>>) |
| MAB21L1 → SPRY2 (>>) |
| MAB21L1 → FMN2 (>>) |
| MAB21L1 → MYRIP (>>) |
| MAB21L1 → TESC (>>) |
| MAB21L1 → LOC100192378 (>>) |
| MAB21L1 → NCRNA00247 (>>) |
| MAB21L1 → GALNTL1 (>>) |
| MAB21L1 → COL4A6 (>>) |
| MAB21L1 → SRPX (>>) |
| MAB21L1 → RHOU (>>) |
| MAB21L1 → PRAC (>>) |
| MAB21L1 → CSRNP3 (>>) |
| MAB21L1 → C8orf79 (>>) |
| MAB21L1 → GSTT2 (>>) |
